Abstract
Gene therapy has not yet met the high expectations of "the early days." However, it is a promising new treatment for lung diseases. Not only single gene disorders such as CF are potential candidates for gene therapy, but also cancer and chronic lung diseases characterized by an imbalance of damaging and protective mechanisms. This review summarizes the recent advances in the development of more efficient gene transfer systems and highlights areas of clinical application of gene therapy.
MeSH terms
-
Animals
-
Asthma / genetics
-
Asthma / therapy
-
Cystic Fibrosis / genetics
-
Cystic Fibrosis / therapy
-
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
-
Gene Transfer Techniques*
-
Genetic Therapy / methods*
-
Genetic Vectors
-
Humans
-
Immunotherapy
-
Lung Diseases / genetics*
-
Lung Diseases / therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / therapy
-
Pulmonary Disease, Chronic Obstructive / genetics
-
Pulmonary Disease, Chronic Obstructive / therapy
-
alpha 1-Antitrypsin / genetics
Substances
-
CFTR protein, human
-
alpha 1-Antitrypsin
-
Cystic Fibrosis Transmembrane Conductance Regulator